Patient Advocacy

Foundation Medicine will be exhibiting at Booth #24109 during the meeting with over 20 poster presentations and 2 oral presentations at #ASCO16. No doubt that genomic profiling, immunotherapy and liquid biopsy are going to have a huge...

More interesting news around PD-L1 for use in Classical Hodgkin lymphoma with specific indications as below. Another increasingly common example of companion diagnostics and personalized immunotherapies. On May 17, 2016, the U.S. Food and Drug...

I thought we covered this more than a year ago but a recent study published in the Annals of Internal Medicine with an accompanying editorial and an article written by Troy Brown, RN on Medscape, there has been some additional dissection of...

With all due respect to Pink Floyd, it seems there is some growing concern the National Cancer Moonshot Initiative is running off course a bit with its recent selection of the "Blue Ribbon Panel" and who is at the table for high level...

Every once in awhile something hits my Facebook feed that makes me wonder how it got there and who means what by it. Beyond the family updates, births, deaths, marriages, divorces, Cubs and Blackhawk updates most recently, I saw one for “Find...

Lot going on in cancer care, data mining, cancer immunotherapy funding last week I thought worth sharing.  Clinical pathways, moonshot, data warehousing/mining, IT, immunotherapy to be key words in cancer care, treatment and research for...